@article{11351,
  keywords = {Dipeptidyl peptidase-4 inhibitors, active-comparator, and Inflammatory Bowel Disease, causal inference, new-user, pharmacoepidemiology, study design, switcher, time-varying exposure, trial emulation},
  author = {T. Wang and J. Wang and Z. Song and E. Miller and V. Pate and Q. Her and J. Yang and S. Charlier and P. Egger and E. Barnes and J. Buse and C. Becker and R. Sandler and C. Meier and S. Jick and T. Sturmer},
  title = {Caution in Handling Switchers in Pharmacoepidemiologic Studies Estimating Treatment Effects: The Example of Dipeptidyl Peptidase-4 Inhibitors and Inflammatory Bowel Disease},
  year = {2025},
  journal = {Am J Epidemiol},
  edition = {2025/03/12},
  isbn = {0002-9262},
  doi = {10.1093/aje/kwaf044},
  note = {1476-6256
Wang, Tiansheng
Wang, Jeanny
Song, Zoey
Miller, Elyse
Pate, Virginia
Her, Qoua
Yang, Jeff
Charlier, Sarah H R
Egger, Pascal
Barnes, Edward L
Buse, John B
Becker, Claudia
Sandler, Robert S
Meier, Christoph
Jick, Susan
Stürmer, Til
Journal Article
United States
Am J Epidemiol. 2025 Mar 5:kwaf044. doi: 10.1093/aje/kwaf044.},
  language = {eng},
}